Pricing Log in Create free account

Pelthos Therapeutics Inc. (PTHS) vs Veru Inc. (VERU)

Pelthos Therapeutics Inc. and Veru Inc. are both Biotechnology companies. Pelthos Therapeutics Inc. and Veru Inc. are of similar size ($35.6M and $35.1M). Veru Inc. has the higher net margin (0.00% vs −199.5%) and the lower return on invested capital (−464.0% vs −82.3%). Across the 15 metrics below, Veru Inc. leads on 9 and Pelthos Therapeutics Inc. on 6.

Valuation

Metric PTHS VERU Biotechnology median
P/E n/m n/m 10.60
P/S 0.78 2.65 9.40
P/B n/m 1.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.88 1.44 9.02
Earnings yield (276.23%) (27.13%) (32.88%)
Free cash flow yield (126.55%) (52.80%) (23.13%)

Profitability

Metric PTHS VERU Biotechnology median
Gross margin 78.59% 43.39% 68.51%
Operating margin (133.42%) 0.00% 0.00%
Net margin (199.50%) 0.00% 0.00%
Free cash flow margin (98.37%) 0.00% 0.00%
Return on equity 2,161.07% (62.25%) (51.96%)
Return on assets (125.04%) (42.29%) (46.06%)
Return on invested capital (82.34%) (464.03%) 0.00%

Growth

Metric PTHS VERU Biotechnology median
Revenue growth (TTM) — 14.18% 6.76%
EPS growth (last fiscal year) (61.12%) 44.64% 29.88%
Revenue growth, 5-year CAGR — (11.89%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PTHS VERU Biotechnology median
Debt to equity (46.58) 0.00 0.00
Current ratio 1.98 4.42 4.97
Net debt to EBITDA (0.45) 0.74 1.01

Dividend

Metric PTHS VERU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PTHS VERU Biotechnology median
Market cap 35.61m 35.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack